ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
2022 · Annals of the Rheumatic Diseases · 832 citations
https://doi.org/10.1136/ard-2022-223296
A
Augusta Ortolan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
151
Papers
2.8K
Citations
26
h-index
48
i10-index
Augusta Ortolan is an academic researcher from Università Cattolica del Sacro Cuore. The author has contributed to research in topics: Spondyloarthritis Studies and Treatments & Rheumatoid Arthritis Research and Therapies & Psoriasis: Treatment and Pathogenesis. The author has an h-index of 26, co-authored 129 publications.
ORCID: 0000-0002-3131-0939Papers by this author
worksAre gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort
2018 · Arthritis Research & Therapy · 70 citations
https://doi.org/10.1186/s13075-018-1705-x
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
2015 · BMC Musculoskeletal Disorders · 52 citations
https://doi.org/10.1186/s12891-015-0620-4
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study
2021 · Clinical Rheumatology · 39 citations
https://doi.org/10.1007/s10067-021-05799-0
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis
2020 · Seminars in Arthritis and Rheumatism · 29 citations
https://doi.org/10.1016/j.semarthrit.2020.02.008
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
2021 · Clinical Rheumatology · 6 citations
https://doi.org/10.1007/s10067-021-05874-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat